Table 3.
Accuracy | Sensitivity | Specificity | PPV | NPV | |
---|---|---|---|---|---|
RF | |||||
SPPT/Ctrl (F1) | 83.33% | 80.00% | 85.71% | 80.00% | 85.71% |
SNPT/Ctrl (F2) | 92.86% | 85.71% | 100% | 100% | 87.50% |
SPPT/SNPT (F3) | 83.33% | 80.00% | 85.71% | 80.00% | 85.71% |
SVM | |||||
SPPT/Ctrl (F1) | 91.67% | 80.00% | 100% | 100% | 87.50% |
SNPT/Ctrl (F2) | 92.86% | 85.71% | 100% | 100% | 87.50% |
SPPT/SNPT (F3) | 91.67% | 80.00% | 100% | 100% | 87.50% |
MLP | |||||
SPPT/Ctrl (F1) | 83.33% | 60.00% | 100% | 100% | 77.78% |
SNPT/Ctrl (F2) | 92.86% | 85.71% | 100% | 100% | 87.50% |
SPPT/SNPT (F3) | 91.67% | 80.00% | 100% | 100% | 87.50% |
F1 set: albumin and 9-OxoODE; F2 set: l-Pyroglutamic acid, Enterostatin human and 9-OxoODE; F3 set: Val-Ser, Methoxyacetic acid and Ethyl 3-hydroxybutyrate